Target intelligence / Profile preview

SMIM14 divergent transcript (SMIM14-DT)

Target
SMIM14-DT
Molecular classification
Other, Long non-coding RNA (lncRNA) transcript
01

Overview

SMIM14 divergent transcript (SMIM14-DT) is a non-coding RNA transcript (probably a long non-coding RNA or lncRNA) located near the SMIM14 protein-coding gene, as catalogued by HGNC and rat genome databases[2][3]. Divergent transcripts are typically arranged head-to-head and are transcribed in the opposite direction from a nearby protein-coding gene. For SMIM14-DT, functional annotation is minimal, and there are no established roles in drug targeting or well-characterized biological processes[2][3]. While non-coding RNAs, including divergent transcripts, increasingly attract research attention for their possible regulatory roles in gene expression and disease, there is currently no direct evidence for SMIM14-DT's involvement in specific biological functions, disease roles, or drug interactions. SMIM14-DT is appropriately described as a long non-coding RNA transcript associated with the SMIM14 gene. It is not a receptor or classical drug target, is not misspelled, but is insufficiently characterized in terms of clinical or therapeutic relevance. All actionable data as a structured target (e.g., therapeutic classification, drug interactions, mechanism, biomarkers) should be considered "null" until further research provides specific biological or clinical evidence. Otherwise, all evidence supports its annotation as a non-coding transcript and not a protein/receptor target[2][3].

Other names
SMIM14 divergent transcriptSMIM14-DT
02

Mechanism of action

No known drugs targeting this transcript; mechanisms of action are thus not established

03

Biological functions

Other
04

Disease associations

Other

Beyond the preview

Go deeper on SMIM14 divergent transcript (SMIM14-DT).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SMIM14 divergent transcript (SMIM14-DT).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call